Table 3.
Proportion of subjects with high CRP (≥0.5 mg/dL) between the study groups.
| Low fitness (n = 2394) | Controls (n = 5930) | p-Value | |
|---|---|---|---|
| Whole cohort | 17.4 (1.1) | 12.4 (0.6) | <0.001 |
| Males | 10.5 (1.3) | 8.3 (0.7) | 0.09 |
| Females | 24.1 (2.1) | 17.2 (1.0) | 0.004 |
| Race | |||
| Whites | 16.2 (2.9) | 12.0 (1.3) | 0.3 |
| Blacks | 22.2 (1.9) | 13.0 (1.9) | <0.001 |
| Mexican-Americans | 20.5 (1.7) | 15.7 (1.9) | 0.002 |
| Others | 14.0 (2.2) | 11.5 (2.2) | 0.9 |
| Co-morbidities | |||
| Hypertension | 34.9 (3.0) | 21.4 (1.6) | 0.003 |
| Hyperlipidemia | 27.8 (5.1) | 19.0 (1.8) | 0.6 |
| BMI categories | |||
| <25 kg/m2 | 6.4 (1.4) | 6.5 (0.6) | 0.9 |
| 25–30 kg/m2 | 12.6 (2.4) | 12.1 (1.0) | 0.8 |
| ≥30 kg/m2 | 37.0 (2.3) | 29.3 (1.6) | 0.004 |
| Chronic Kidney Disease (GFR < 60 mL/min/1.73 m2) | 14.9 (3.2) | 19.0 (2.5) | 0.3 |
| Smoking status | |||
| Never-smoker | 23.6 (2.9) | 14.1 (1.1) | 0.002 |
| Former-smoker | 34.2 (1.8) | 12.4 (2.5) | 0.003 |
| Active-smoker | 21.6 (2.4) | 14.6 (1.4) | 0.03 |